Stocks of the Hour: Woolworths, Coles, Premier Investments

Company News

by Melissa Darmawan

Supermarket giant Woolworths (ASX:WOW) has emerged as a rival buyer for Priceline owner Australian Pharmaceutical Industries (ASX:API) with a $870 million offer, a move that could see Woolies spread its wings into the healthcare space. The bid is a counter to a $760 million offer from Wesfarmers (ASX:WES), the owner of Bunnings and Officeworks. Shares in Woolworths (ASX:WOW) closed 0.4 per cent higher at $39.99, Shares in Australian Pharmaceutical Industries (ASX:API) surged 16 per cent at $1.74.

Meanwhile, rival Coles (ASX:COL) has been taken to court by the Fair Work Commission, which claims the supermarket giant underpaid 7,800 staff last year by $115 million. Shares in Coles (ASX:COL) closed 0.5 per cent lower at $17.65.

Premier Investments (ASX:PMV), the owner of six brands including Just Jeans, and Peter Alexander said in a trading update that sales are on its way out of the red. Over the past three weeks, stores around the globe have progressively re-opened, with sales up 10.1 per on the same three weeks compared to last year. Shares in Premier Investments (ASX:PMV) closed 0.8 per cent lower at $29.98.

Click on the ASX code and company for the full story.

Are you a 708 sophisticated investor?

A sophisticated investor is defined under Section 708 of the Corporations Act (net assets of $2.5 million or annual incomes in excess of $250,000).

They are eligible to receive information regarding wholesale investment opportunities that are not available to regular or retail investors.

Please subscribe if you would like to be alerted to these types of opportunities.